{"id":"https://openalex.org/W2017833528","doi":"https://doi.org/10.1046/j.1365-2133.1998.1390s2003.x","title":"Pharmacology of adapalene","display_name":"Pharmacology of adapalene","alternate_titles":[],"publication_year":1998,"publication_date":"1998-09-01","ids":{"openalex":"https://openalex.org/W2017833528","doi":"https://doi.org/10.1046/j.1365-2133.1998.1390s2003.x","mag":"2017833528","pmid":"https://pubmed.ncbi.nlm.nih.gov/9990413"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2133.1998.1390s2003.x","doi":"https://doi.org/10.1046/j.1365-2133.1998.1390s2003.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2133.1998.1390s2003.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017833528"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5098455408","display_name":"MichelL","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120458","display_name":"Galderma (France)","ror":"https://ror.org/034kxvk28","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210120458","https://openalex.org/I4210163806"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MichelL","raw_affiliation_strings":["Galderma R & D, 635 route des Lucioles, BP67, 06902 Sophia Antipolis cedex, Valbonne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma R & D, 635 route des Lucioles, BP67, 06902 Sophia Antipolis cedex, Valbonne, France","institution_ids":["https://openalex.org/I4210120458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098499834","display_name":"Jomard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120458","display_name":"Galderma (France)","ror":"https://ror.org/034kxvk28","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210120458","https://openalex.org/I4210163806"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jomard","raw_affiliation_strings":["Galderma R & D, 635 route des Lucioles, BP67, 06902 Sophia Antipolis cedex, Valbonne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma R & D, 635 route des Lucioles, BP67, 06902 Sophia Antipolis cedex, Valbonne, France","institution_ids":["https://openalex.org/I4210120458"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5098455409","display_name":"D\u00e9marchez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120458","display_name":"Galderma (France)","ror":"https://ror.org/034kxvk28","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210120458","https://openalex.org/I4210163806"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D\u00e9marchez","raw_affiliation_strings":["Galderma R & D, 635 route des Lucioles, BP67, 06902 Sophia Antipolis cedex, Valbonne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma R & D, 635 route des Lucioles, BP67, 06902 Sophia Antipolis cedex, Valbonne, France","institution_ids":["https://openalex.org/I4210120458"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210120458"],"apc_list":{"value":3731,"currency":"GBP","value_usd":4920},"apc_paid":null,"fwci":2.8206,"has_fulltext":false,"cited_by_count":113,"citation_normalized_percentile":{"value":0.89004806,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"139","issue":"s52","first_page":"3","last_page":"7"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adapalene","display_name":"adapalene","score":1.0},{"id":"https://openalex.org/keywords/synthetic-retinoids","display_name":"synthetic retinoids","score":0.8650000095367432},{"id":"https://openalex.org/keywords/acne-treatment","display_name":"acne treatment","score":0.9350000023841858},{"id":"https://openalex.org/keywords/retinoic-acid-receptor-gamma","display_name":"retinoic acid receptor gamma","score":0.8450000286102295},{"id":"https://openalex.org/keywords/retinoic-acid-receptor-beta","display_name":"retinoic acid receptor beta","score":0.968999981880188},{"id":"https://openalex.org/keywords/keratinocyte-proliferation","display_name":"keratinocyte proliferation","score":0.7940000295639038},{"id":"https://openalex.org/keywords/keratinocyte-differentiation","display_name":"keratinocyte differentiation","score":0.972000002861023},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.9269999861717224},{"id":"https://openalex.org/keywords/ap-1-transcription-factor","display_name":"AP-1 transcription factor","score":0.7440000176429749},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.7889999747276306},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2777140388","wikidata":"https://www.wikidata.org/wiki/Q352348","display_name":"Adapalene","level":5,"score":0.9984580874443054},{"id":"https://openalex.org/C2775954498","wikidata":"https://www.wikidata.org/wiki/Q420418","display_name":"Retinoid","level":4,"score":0.6833928823471069},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6112194657325745},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5925689935684204},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.5794315338134766},{"id":"https://openalex.org/C2779306117","wikidata":"https://www.wikidata.org/wiki/Q3981685","display_name":"Tazarotene","level":3,"score":0.5207381248474121},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4682380259037018},{"id":"https://openalex.org/C2777074287","wikidata":"https://www.wikidata.org/wiki/Q1473931","display_name":"Keratinocyte","level":3,"score":0.465667724609375},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.42763644456863403},{"id":"https://openalex.org/C2779963572","wikidata":"https://www.wikidata.org/wiki/Q29417","display_name":"Tretinoin","level":4,"score":0.42760026454925537},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3509034514427185},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3429795503616333},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32060253620147705},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19015106558799744},{"id":"https://openalex.org/C148738053","wikidata":"https://www.wikidata.org/wiki/Q210861","display_name":"Cellular differentiation","level":3,"score":0.14473092555999756},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.14448246359825134},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1345566213130951},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.05361086130142212},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C2778885487","wikidata":"https://www.wikidata.org/wiki/Q411424","display_name":"Benzoyl peroxide","level":4,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C44228677","wikidata":"https://www.wikidata.org/wiki/Q181898","display_name":"Polymerization","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068816","descriptor_name":"Adapalene","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002454","descriptor_name":"Cell Differentiation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018160","descriptor_name":"Receptors, Cytoplasmic and Nuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2133.1998.1390s2003.x","doi":"https://doi.org/10.1046/j.1365-2133.1998.1390s2003.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2133.1998.1390s2003.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:9990413","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9990413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of dermatology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1916260177","https://openalex.org/W1927684145","https://openalex.org/W1980865611","https://openalex.org/W1984509210","https://openalex.org/W1985452221","https://openalex.org/W1997680677","https://openalex.org/W2004002827","https://openalex.org/W2011467252","https://openalex.org/W2015014803","https://openalex.org/W2016814951","https://openalex.org/W2017719948","https://openalex.org/W2019032943","https://openalex.org/W2022708373","https://openalex.org/W2034926383","https://openalex.org/W2049791242","https://openalex.org/W2069524780","https://openalex.org/W2070547356","https://openalex.org/W2076235025","https://openalex.org/W2078700641","https://openalex.org/W2079265807","https://openalex.org/W2115494923","https://openalex.org/W2120176836","https://openalex.org/W2407848424","https://openalex.org/W4246892132","https://openalex.org/W6651336719"],"related_works":["https://openalex.org/W2144493708","https://openalex.org/W2033862009","https://openalex.org/W1987495109","https://openalex.org/W2114773400","https://openalex.org/W1983077552","https://openalex.org/W2029321435","https://openalex.org/W2086418510","https://openalex.org/W2128687148","https://openalex.org/W3081960522","https://openalex.org/W3193397507"],"abstract_inverted_index":{"Adapalene,":[0],"a":[1,5,74],"synthetic":[2],"retinoid,":[3],"is":[4,30,81,99],"new":[6],"drug":[7],"proposed":[8],"for":[9],"the":[10,17,55,87,92,97],"treatment":[11],"of":[12,24,89,96,112],"acne":[13],"patients.":[14],"Studies":[15],"on":[16,33,66,91],"in":[18,21,84],"vitro":[19],"and":[20,35,38,60,63,68],"vivo":[22],"pharmacology":[23],"adapalene":[25,41,90,113],"have":[26],"shown":[27],"that":[28],"it":[29,121],"very":[31],"active":[32],"cell":[34,94],"tissue":[36],"proliferation":[37,67],"differentiation.":[39],"Furthermore,":[40],"has":[42,122],"anti-inflammatory":[43],"potential":[44],"as":[45],"determined":[46],"by":[47,73,102],"its":[48,64,103,129],"anti-AP1":[49],"activity.":[50],"Adapalene":[51],"interacts":[52],"selectively":[53],"with":[54,105],"nuclear":[56],"receptors":[57],"RAR":[58,61,75,79,106],"beta":[59,80],"gamma,":[62],"activity":[65],"differentiation":[69],"can":[70],"be":[71],"blocked":[72],"beta-gamma":[76],"antagonist.":[77],"Because":[78],"not":[82],"expressed":[83],"human":[85],"keratinocytes,":[86],"effect":[88],"major":[93],"type":[95],"epidermis":[98],"certainly":[100],"mediated":[101],"interaction":[104],"gamma.":[107],"The":[108],"unique":[109],"pharmacological":[110],"properties":[111],"may":[114],"explain":[115],"why,":[116],"when":[117],"compared":[118],"to":[119,128],"tretinoin,":[120],"an":[123],"improved":[124],"therapeutic":[125],"ratio":[126],"due":[127],"better":[130],"tolerance.":[131]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017833528","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
